Ocular side effects of immune checkpoint inhibitors are considered rare but may be underreported.
Nathan Scott, MD
Nathan Scott, MD is a physician-scientist with a clinical focus on vitreoretinal diseases and surgery, as well as a special interest in ocular oncology. He is assistant professor of ophthalmology and the chief of the Ocular Oncology Division at the Shiley Eye Institute and Viterbi Family Department of Ophthalmology. He also serves on the executive board of the Minority Ophthalmology Mentoring program and is a member of the Young Ophthalmology Advocacy subcommittee.